Altered myocardial high-energy phosphate metabolites in patients with dilated cardiomyopathy

This publication has 18 references indexed in Scilit:

• Regional Myocardial Metabolism of High-Energy Phosphates during Isometric Exercise in Patients with Coronary Artery Disease
  New England Journal of Medicine, 1990
• Phosphate metabolite imaging and concentration measurements in human heart by nuclear magnetic resonance
  Magnetic Resonance in Medicine, 1990
• In vivo phosphorus-31 spectroscopic imaging in patients with global myocardial disease
  The American Journal of Cardiology, 1990
• Improvement in myocardial performance without a decrease in high-energy phosphate metabolites after isoproterenol in Syrian cardiomyopathic hamsters.
  Circulation, 1988
• Measurement of Phosphocreatine to ATP Ratio in Normal and Diseased Human Heart by ³¹P Magnetic Resonance Spectroscopy Using the Rotating Frame‐Depth Selection Techniquea
  Annals of the New York Academy of Sciences, 1987
• Effects of the anti-cancer drug adriamycin on the energy metabolism of rat heart as measured by in vivo 31P-NMR and implications for adriamycin-induced cardiotoxicity
  Biochimica et Biophysica Acta (BBA) - Molecular Cell Research, 1987
• The preventive effect of verapamil on ethanol-induced cardiac depression: phosphorus-31 nuclear magnetic resonance and high-pressure liquid chromatographic studies of hamsters.
  Circulation, 1987
• Evaluation of the hereditary Syrian hamster cardiomyopathy by 31P nuclear magnetic resonance spectroscopy: improvement after acute verapamil therapy.
  Circulation Research, 1986
• Noninvasive Study of High-Energy Phosphate Metabolism in Human Heart by Depth-Resolved ³¹ P NMR Spectroscopy
  Science, 1985
• Diagnosis and therapeutic evaluation of a pediatric case of cardiomyopathy using phosphorus-31 nuclear magnetic resonance spectroscopy
  Journal of the American College of Cardiology, 1985